Ivabradine extended release (Abbott Healthcare)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIvabradine extended release (Abbott Healthcare)
Drug Alias NameIvabradine prolonged release
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHyperpolarization-activated cyclic nucleotide-gated channel blockers
TargetsHyperpolarization-activated cyclic nucleotide-gated channel
Therapy Area/IndicationsAngina PectorisHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Laboratories
Inactive CompaniesN/A
Active IndicationsAngina PectorisHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A